Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia.
Buster MannheimerHenrik FalhammarJan CalissendorffJakob SkovJonatan D LindhPublished in: Journal of psychopharmacology (Oxford, England) (2021)
This study revealed a dramatically increased risk of hyponatremia exclusively related to newly initiated treatment. Consequently, even subtle symptoms consistent with hyponatremia during the first weeks of SSRI treatment should prompt analysis of sodium levels. In patients treated with SSRIs for several months or years, other causes should primarily be sought in the event of hyponatremia.